About

About NeXtGen Biologics Inc. NeXtGenTM Biologics Inc. is a medical device company which owns a suite of patents encompassing extracellular matrix (ECM) platform technology derived from the Axolotl, an amphibian known for its regenerative properties. Leveraging a world-class team with expertise in medical devices and breakthrough tissue technologies, the company expects to offer physicians advanced platform solutions designed to treat and manage a myriad of complex conditions seen in wounds, general surgery, trauma, plastic surgery, cardiovascular diseases, neurosurgery, orthopedics and ophthalmology.